LSE · GDR.L
Genedrive Plc
£0.01+£0.00 (+0.82%)
Genedrive Plc’s quoted price sits in the lower half of its reported 52-week range, 36.58% below the high.
Loading market information…
LSE · CHLL.L · GBp
Stock price, earnings
Quote as of Oct 30, 2026, 08:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · GBp. Historical prices are not a forecast.
Chill Brands Group PLC’s quoted price sits in the lower half of its reported 52-week range, 85.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Chill Brands Group PLC’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Chill Brands Group PLC, established in 2014, operates from its headquarters in London, United Kingdom. The company focuses on the innovation, manufacturing, and distribution of cannabidiol (CBD) consumer items and other lifestyle products across the United States and the United Kingdom. Its product range includes alternatives to tobacco, such as smokable items and chewable pouches. Additionally, the company provides a variety of CBD-infused goods, including oral tinctures, soft-gel capsules, massage oils, and cosmetic products for topical application. In August 2021, the entity formerly known as Zoetic International Plc officially adopted its current name, Chill Brands Group PLC.
Latest available per-share figures in GBP. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
£0.01+£0.00 (+0.82%)
Genedrive Plc’s quoted price sits in the lower half of its reported 52-week range, 36.58% below the high.
£0.02+£0.00 (+15.75%)
Proteome Sciences plc’s quoted price sits in the lower half of its reported 52-week range, 61.59% below the high.
£0.07£0.00 (0.0%)
Tissue Regenix Group plc’s quoted price sits in the lower half of its reported 52-week range, 89.02% below the high.
£0.09-£0.00 (-2.78%)
MyHealthChecked PLC’s quoted price sits in the lower half of its reported 52-week range, 58.33% below the high.
£0.00£0.00 (0.0%)
N4 Pharma Plc’s quoted price sits in the lower half of its reported 52-week range, 52.5% below the high.
£0.00-£0.00 (-2.86%)
Theracryf Plc’s quoted price sits in the lower half of its reported 52-week range, 36.57% below the high.
£0.01-£0.00 (-5.48%)
Cambridge Nutritional Sciences plc’s quoted price sits in the lower half of its reported 52-week range, 47.68% below the high.
£0.09-£0.00 (-2.4%)
CRISM Therapeutics Corporation’s quoted price sits in the lower half of its reported 52-week range, 53.84% below the high.
